Northland Capmk Brokers Boost Earnings Estimates for CVE:HIV

HIVE Blockchain Technologies Ltd. (CVE:HIVFree Report) – Equities research analysts at Northland Capmk boosted their Q3 2026 earnings per share estimates for HIVE Blockchain Technologies in a research report issued to clients and investors on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings of $0.11 per share for the quarter, up from their prior forecast of $0.07.

Several other research analysts also recently issued reports on the company. Roth Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Four investment analysts have rated the stock with a strong buy rating, According to MarketBeat.com, the stock has an average rating of “Strong Buy”.

Check Out Our Latest Analysis on HIVE Blockchain Technologies

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies (CVE:HIVGet Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported C($0.08) earnings per share for the quarter, beating the consensus estimate of C($0.12) by C$0.04. During the same quarter last year, the firm posted ($0.39) earnings per share.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Recommended Stories

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.